» Articles » PMID: 21029338

ASH Position Paper: Adherence and Persistence with Taking Medication to Control High Blood Pressure

Overview
Date 2010 Oct 30
PMID 21029338
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Nonadherence and poor or no persistence in taking antihypertensive medications results in uncontrolled high blood pressure, poor clinical outcomes, and preventable health care costs. Factors associated with nonadherence are multilevel and relate not only to the patient, but also to the provider, health care system, health care organization, and community. National guideline committees have called for more aggressive approaches to implement strategies known to improve adherence and technologies known to enable changes at the systems level, including improved communication among providers and patients. Improvements in adherence and persistence are likely to be achieved by supporting patient self-management, a team approach to patient care, technology-supported office practice systems, better methods to measure adherence, and less clinical inertia. Integrating high blood pressure control into health care policies that emphasize and improve prevention and management of chronic illness remains a challenge. Four strategies are proposed: focusing on clinical outcomes; empowering informed, activated patients; developing prepared proactive practice teams; and advocating for health care policy reform. With hypertension remaining the most common reason for office visits, the time is now.

Citing Articles

Automatic transmission of home blood pressure data can be effective in managing hypertension: a systematic review and meta-analysis.

Kaihara T, Intan-Goey V, Scherrenberg M, Falter M, Kario K, Akashi Y Eur Heart J Digit Health. 2023; 3(4):638-653.

PMID: 36710899 PMC: 9779889. DOI: 10.1093/ehjdh/ztac049.


Factors Influencing Public Awareness of and Attitudes Toward Palliative Care: A Cross-Sectional Analysis of the 2018 HINTS Data.

Lu X, Liu J Front Public Health. 2022; 10:816023.

PMID: 35462828 PMC: 9021382. DOI: 10.3389/fpubh.2022.816023.


Current status of adherence interventions in hypertension management in Asian countries: A report from the HOPE Asia Network.

Shin J, Chia Y, Heo R, Kario K, Turana Y, Chen C J Clin Hypertens (Greenwich). 2020; .

PMID: 33350024 PMC: 8029547. DOI: 10.1111/jch.14104.


Assessing Barriers to and Level of Adherence to Hypertension Therapy among Palestinians Living in the Gaza Strip: A Chance for Policy Innovation.

Abu-El-Noor N, Aljeesh Y, Bottcher B, Abu-El-Noor M Int J Hypertens. 2020; 2020:7650915.

PMID: 33062318 PMC: 7555458. DOI: 10.1155/2020/7650915.


Classifying intervention modifications in the community pharmacy context: A demonstration study.

Teeter B, Thomas J, Curran G, Balamurugan A J Am Pharm Assoc (2003). 2020; 60(6):e230-e235.

PMID: 32839135 PMC: 7655524. DOI: 10.1016/j.japh.2020.07.023.


References
1.
Schroeder K, Fahey T, Ebrahim S . Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004; (2):CD004804. PMC: 9036187. DOI: 10.1002/14651858.CD004804. View

2.
Carter B, Zillich A, Elliott W . How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens (Greenwich). 2003; 5(1):31-7. PMC: 8101839. DOI: 10.1111/j.1524-6175.2003.01460.x. View

3.
Kripalani S, Yao X, Haynes R . Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007; 167(6):540-50. DOI: 10.1001/archinte.167.6.540. View

4.
. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992; 267(9):1213-20. DOI: 10.1001/jama.1992.03480090061028. View

5.
. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288(23):2981-97. DOI: 10.1001/jama.288.23.2981. View